Kristin N. Varhaug

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

Brage Brakedal, Christian Dölle, Frank Riemer et al. · Cell Metabolism · 2022 · 302 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Neurofilament light chain predicts disease activity in relapsing-remitting MS

Kristin N. Varhaug, Christian Barro, Kjetil Bjørnevik et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 164 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus

Maaike C. de Vries, David A. Brown, Mitchell E. Allen et al. · Journal of Inherited Metabolic Disease · 2020 · 68 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis

Kristin N. Varhaug, Christian A. Vedeler, Kjell‐Morten Myhr et al. · Mitochondrion · 2016 · 60 citations

Life Sciences, Neurology, Neuroscience +9

Serum biomarkers in primary mitochondrial disorders

Kristin N. Varhaug, Omar Hikmat, Hanne Linda Nakkestad et al. · Brain Communications · 2021 · 28 citations · Full text

Life Sciences, Genetics, Neurology +15